Hims & Hers Health, Inc. (HIMS)
Hims and Hers Stock Drops Weight as Earnings Loom
Hims & Hers Health Inc (NYSE:HIMS) stock has had a roller coaster week.
Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage
HIMS stock fell after the FDA said the shortages in Novo Nordisk's weight-loss drug has been resolved. The post Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage appeared first on Investor's Business Daily.
HIMS stock crashes 25% on Friday after this key FDA update
Shares of Hims & Hers Health plunged a massive 25% on Friday to hit an intraday low of around $49.01. The massive crash came after the US Food and Drug Administration (FDA) announced the end of the shortage of Novo Nordisk's weight-loss drugs.
Hims & Hers Health: The Ultimate Pick For The Next Decade
Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. I provide multiple perspectives in this article, offering readers different viewpoints to draw their own conclusions. There are historical references, future valuations, and timeless investing lessons. There are five primary growth drivers that should continue to turbocharge HIMS' future revenue. I cover them all in detail.
Why Hims & Hers Stock Dropped Today
Hims & Hers Health (HIMS -4.55%) tumbled 5.6% through 12:20 p.m. ET Thursday after Bank of America analysts gave mixed messages on the stock this morning.
Hims & Hers stock surges 23%: Telehealth company announces expansion into blood testing weeks after Super Bowl buzz
Amid a month of skyrocketing stock prices and unprecedented social media buzz, Hims & Hers Health is expanding its territory into at-home blood testing and diagnostics.
Atlanta Fed's Bostic, tariffs, Hims & Hers: Market Domination
Julie Hyman and Seana Smith are joined by key experts as take a closer look at the trending stories on Wall Street on Market Domination. Federal Reserve Bank of Atlanta president Raphael Bostic sits down with Yahoo Finance Senior Fed Reporter Jennifer Schonberger to discuss how the central bank is navigating its recent pause on interest rate hikes amid uncertainty around fiscal policy.
Hims & Hers Stock Hits Record High on Blood-Testing Lab Acquisition
Hims & Hers Health (HIMS) shares jumped roughly 20% to a fresh record high on Wednesday following the announcement that the company acquired lab testing facility Trybe Labs.
Why Hims & Hers Health Stock Is Skyrocketing Today
Shares of Hims & Hers Health Inc (HIMS 20.27%) are flying higher on Wednesday. The company's stock gained 21.7% as of 2:00 p.m.
Hims & Hers to offer at-home blood draws and lab testing with new acquisition
Hims and Hers Health has acquired at-home lab testing facility Trybe Labs. The acquisition will allow the telehealth company to provide at-home lab testing through its platform.
Hims & Hers Q4 Preview: Is The Super Bowl Ad Worth $5B In Market Cap? (Rating Downgrade)
Hims & Hers Health stock has surged 212% since my previous “buy” rating. Despite strong revenue and earnings growth expectations, I recommend holding off at the moment. Hims & Hers has consistently beat its revenue and earnings for the past several quarters, while the management has raised their forward expectations as a result of their Personalized solutions. However, the latest surge in the stock price is attributed to its provocative Super Bowl ad and favorable outlook on the regulatory landscape after RFK Jr.'s appointment as the Health Secretary.
Hims & Hers Earnings Could Be a Game Changer—What to Do Now
There are a few stocks that come along every once in a while, arriving to change the way an old-fashioned industry works and operates. When investors get lucky enough to find one of them, it can typically bring on life-changing returns, even retiring them from active work if they choose to go that route.
